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Abstract: The ACGT project which aims to foster the sharing of research result 
from both, clinical and molecular research for the benefit of cancer patients 
uses ontology-driven semantic services. One novelty ACGT provides is a tool 
named ObTiMA which allows to build questionnaires directly from the ACGT 
Master Ontology. This will facilitate the process of creating Case Report 
Forms. Furthermore, the clinical data collected is already annotated in the terms 
of the ontology. 
The ACGT Project and the ACGT Master Ontology 
The Advancing Clinico-Genomic Trials on Cancer (ACGT) integrated project aims 
to set up a semantic grid infrastructure in support of multi-centric, post-genomic 
clinical trials [1, 2]. This system will enable the smooth and prompt transfer of 
laboratory findings to the clinical management and treatment of patients. In order to 
meet this goal, the ACGT project needs an ontology to provide the basis for semantic 
integration within the project. The ACGT MO [3] intents to represent the domain of 
cancer research and management in a computationally tractable manner. As such, we 
regard it as a domain ontology. The initial version of the ACGT MO that was made 
public in the internet consists of 1300 classes. The ontology is written in OWL-DL [4] 
and presented as an .owl file.  
ObTiMA 
ACGT aims to provide solutions that demonstrate the possibility of creating data in 
an ontology-governed way. To explore this approach, ObTiMA has been developed. 
It enables those who undertake clinical trials to set up patient data management 
systems with comprehensive metadata in terms of the ACGT-MO [5]. This allows 
seamless integration of data collected in these systems into the ACGT mediator 
architecture. The main components of ObTiMA are the Trial Builder and the patient 
data management system. The Trial Builder allows a trial chairman to define the 
master protocol, the CRFs and the treatment plan for the trial, in a way that is both 
semantically compliant with the ACGT MO and user-friendly. From these definitions, 
the patient data management system can be set up automatically. The data collected in 
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the trial is stored in trial databases whose comprehensive metadata has been rendered 
in terms of the ACGT-MO.  
In the following, we briefly describe how the Trial Builder allows the clinician to 
define all information needed to make integration possible. In setting up a trial, 
clinicians want to focus on the user interfaces and try to integrate and adapt them into 
the specific workflow of the clinical trial planned. They should not be concerned with 
theoretical aspects and design principles of databases or ontological metadata. 
Therefore, in ObTiMA, the trial chairman defines both, by creating the CRFs for his 
trials. He is assisted in defining the questions on the CRFs, the order in which the 
questions will be queried, and constraints on the answer possibilities. Creating a 
question on the CRF is supported by simply selecting appropriate concepts from the 
ACGT MO. For example, we assume that the clinician wants to collect all 
information on the patient’s gender. He observes that a relation between the classes 
“Patient” and “Gender” does exist. In creating the corresponding question, he simply 
has to choose the class Gender. The attributes required in order to create the question 
on the CRF are then determined mostly automatically. E.g. as answer possibilities for 
the question the values Male, Female, and AmbiguousGender are suggested to choose 
from, because the class Gender is defined as an enumeration in the ontology 
containing these values and a multiple choice question is subsequently automatically 
created on the CRF. This procedure implements the semantics of the ontology in the 
CRFs in an automatic fashion. We expect that the description alluded to above be a 
path from the ontology starting at the class Patient, as this is normally the focal point 
of CRFs.  
In clinical computer systems a key issue for semantic interoperability is the 
reliability of subsequent coding of data obtained in clinical practice and shared with 
others. Recent studies show that the accuracy of SNOMED coding is only slightly 
over 50 % given three different scenarios [6, 7]. We hold that techniques need to be 
found that make subsequent coding superfluous. One example of such a technique is 
ObTiMA.  
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